首页> 外国专利> METHOD FOR PREDICTING THE EFFICIENCY OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION, WHO HAVE SUFFERED A STROKE

METHOD FOR PREDICTING THE EFFICIENCY OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION, WHO HAVE SUFFERED A STROKE

机译:预测发生卒中的房颤患者抗凝治疗效率的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine and is a method for evaluating the effectiveness of anticoagulant therapy in patients with atrial fibrillation (AF) who have suffered a stroke, characterized in that before the appointment of anticoagulant therapy with new oral anticoagulants (NOAC) the patient is taking blood from the peripheral vein, 10 mcl of which is placed in Goryaev chamber with a mirror coating and analyzed by a laser phase-interference microscope, measuring the phase altitude of 40–50 erythrocytes in the sample; determine the average maximum dY1 and the average minimum dY2 red blood cell phase altitude, calculate the erythrocyte oxygenation coefficient dY2/dY1; the values of dY2/dY1 of 0.085 to 0.2 are considered normal; the values of dY2/dY1  0.085 and the values of dY2/dY1  0.2 indicate an abnormality of blood rheology; 17 weeks after initiation of therapy, the NOAC study is repeated; achieve or store the values dY2/dY1 of 0.085 to 0.2 are considered a sign of the effectiveness of therapy, and the values of dY2/dY1  0.085 and the values of dY2/dY1  0.2 indicate its inefficiency.;EFFECT: possibility to evaluate the effectiveness of anticoagulant therapy of NOAC in patients with AF who have suffered a stroke.;1 cl, 2 ex
机译:药物发明领域本发明涉及药物,并且是一种评估抗凝疗法对中风的房颤患者的有效性的方法,其特征在于,在任命新的口服抗凝剂进行抗凝疗法之前( NOAC)患者正在从外周静脉采血,将其10 mcl的血放在带有镜面涂层的Goryaev室中,并通过激光相位干涉显微镜进行分析,测量样品中40–50个红细胞的相高度;确定平均最大dY 1 和平均最小dY 2 红细胞相高度,计算红细胞充氧系数dY 2 / dY 1 ; dY 2 / dY 1 的值为0.085至0.2。 dY 2 / dY 1 <0.085的值和dY 2 / dY 1 2 / dY 1 值被认为是治疗有效性的标志,而dY 2 / dY 1 <0.085和dY 2 / dY 1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号